---
schema_version: "secwatch.filing_event.v1"
accession: "0001553350-24-000088"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2024-09-23T23:59:59+00:00"
generated_at: "2026-05-31T02:28:59.768258+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TOI CFO Mihir Shah resigns; Rob Carter promoted to CFO effective Oct 14

## Summary
- CFO Mihir Shah resigns effective October 14, 2024, to pursue other opportunities; departure not related to operations or accounting policies.
- Rob Carter, SVP of Finance since December 2021, promoted to CFO effective October 14, 2024; will serve as principal financial and accounting officer.
- Carter brings over a decade of healthcare finance leadership, including roles at Hoag Health System, Kaiser Permanente, SCAN Health Plan, and McKesson.
- Carter's initial base salary is $375,000 with a 40% target bonus; equity award to be granted on next regular quarterly grant date.
- Shah will assist transition as an advisor under a consulting arrangement at an agreed hourly rate.

## SEC filing metadata
- accession: 0001553350-24-000088
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2024-09-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/0001553350-24-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001553350-24-000088
- JSON: https://secwatch.observer/filing/0001553350-24-000088.json
- Plain text: https://secwatch.observer/filing/0001553350-24-000088.txt

## Key facts
- Executive change
  Robert Carter was appointed as Chief Financial Officer at Oncology Institute, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 20, 2024, the Company appointed Robert Carter to replace Mr. Shah as the Company’s Chief Financial Officer, with effect on October 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/0001553350-24-000088-index.htm
- Executive change
  Mihir Shah resigned as Chief Financial Officer at Oncology Institute, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On September 19, 2024, Mihir Shah, the Chief Financial Officer, principal financial officer, and principal accounting officer of The Oncology Institute, Inc. (the “Company”), delivered a notice of resignation effective as of October 14, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/0001553350-24-000088-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.